Ex-Apple Health director sells consumer health data platform to Invitae for $325M 

Listen
Text
  • Small
  • Medium
  • Large

Medical genetics company Invitae inked an agreement to acquire consumer health tech company Ciitizen, which was founded by former Apple Health Director Anil Sethi in 2017. 

Four details: 

1. Invitae will purchase Ciitizen for $325 million and will issue an additional $225 million in restricted stock units to new employees who join the company in connection with the acquisition, according to a Sept. 7 news release. 

2. Mr. Sethi left Apple Health to start Ciitizen after his sister died from cancer; the company's mission is to improve patient health records so researchers and physicians can more easily use that information to improve cancer care. 

3. By acquiring Ciitizen, Invitae will provide patients using its platform access to a centralized hub for their genomic and clinical data. Invitae's focus is on aggregating genetic test results into a single service that makes genetic data accessible for research, with patient consent. 

4. Invitae has completed 13 acquisitions over the past five years and has raised more than $1.4 billion since the beginning of 2021.

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars